1.6600
24-2月-25 16:45:00
15 分の遅延
株式
-0.1000
-5.68%
本日の幅
1.6600 - 1.8600
ISIN
N/A
ソース
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 10 2022 09:00:00 提供 Nasdaq GlobeNewswire